Strategic Partners A/S
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.
Market Cap & Net Worth: Strategic Partners A/S (1TB0)
Strategic Partners A/S (F:1TB0) has a market capitalization of $3.16 Million (€3.08 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #35470 globally and #4197 in its home market, demonstrating a -4.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Strategic Partners A/S's stock price €74.40 by its total outstanding shares 41349 (41.35K).
Strategic Partners A/S Market Cap History: 2026 to 2026
Strategic Partners A/S's market capitalization history from 2026 to 2026. Data shows growth from $3.16 Million to $3.16 Million (0.00% CAGR).
Strategic Partners A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Strategic Partners A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1TB0 by Market Capitalization
Companies near Strategic Partners A/S in the global market cap rankings as of March 19, 2026.
Key companies related to Strategic Partners A/S by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Strategic Partners A/S Historical Marketcap From 2026 to 2026
Between 2026 and today, Strategic Partners A/S's market cap moved from $3.16 Million to $ 3.16 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €3.16 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Strategic Partners A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.16 Million USD |
| MoneyControl | $3.16 Million USD |
| MarketWatch | $3.16 Million USD |
| marketcap.company | $3.16 Million USD |
| Reuters | $3.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.